相关实验视频

Updated: May 31, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

抗血栓策略在生物假体大动脉置换中的比较有效性:一个网络元分析

Noritsugu Naito¹, Hisato Takagi¹

¹Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.

|January 22, 2025

概括

对于生物假体大动脉置换 (bAVR),单独的抗血小板治疗 (AP) 显示出比其他抗血小板策略更好的结果. 与抗凝血疗法 (AC) 相比,这种方法可以减少死亡率和出血事件.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
医疗干预医疗干预

背景情况:

生物假体大动脉置换 (bAVR) 需要抗血栓治疗来预防并发症.
对bAVR患者的最佳抗血栓策略仍然是正在进行的临床评估的主题.
目前的指导方针提供了各种各样的建议,强调了对比疗效研究的必要性.

研究的目的:

在接受bAVR的患者中比较不同抗血栓策略的有效性和安全性.
在各种治疗方案中评估包括死亡率,血栓塞栓事件和出血事件在内的结果.
确定最佳的抗血栓治疗方法,以改善bAVR后患者的治疗结果.

主要方法:

进行了系统的元分析和网络元分析,搜索到2024年5月的文献.
包括的研究比较了接受抗凝治疗 (AC) 和未接受抗凝治疗的患者之间的结果.
分析的治疗类别:单独AC,AC与抗血小板治疗 (AP),单独AP,没有抗血小板治疗.

主要成果:

在患有AC和没有AC的患者之间,没有观察到任何原因死亡率或血栓栓塞事件的显著差异.
与没有AC的患者相比,接受AC的患者经历了明显更高的出血事件率.
网络元分析表明,单单AP与较低的死亡率和较少的出血事件有关,而不是基于AC的策略.

结论:

单独的抗血小板治疗 (AP) 似乎与接受bAVR的患者的优异结果有关.
与其他抗血栓策略相比,单单AP就显示出对死亡率和出血风险的有利概况.
这些发现表明,可能会转向单独使用AP作为bAVR的首选抗血栓治疗策略.

关键词:

这是一种抗凝血药物.生物假肢大动脉替换术这是一个元分析.

更多相关视频

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...